We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.14%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.97B
AUM Growth
-$688M
(-10%)
Cap. Flow
-$778M
Cap. Flow
% of AUM
-13.04%
Top 10 Holdings %
Top 10 Hldgs %
12.48%
Holding
1,150
New
217
Increased
235
Reduced
398
Closed
276
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$51.8M |
| 2 |
Visa
V
|
+$46.4M |
| 3 |
Comcast
CMCSA
|
+$45.7M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$36.3M |
| 5 |
Norfolk Southern
NSC
|
+$30.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$52.2M |
| 2 |
Starbucks
SBUX
|
+$51M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$41.7M |
| 4 |
Eli Lilly
LLY
|
+$40.3M |
| 5 |
Booking.com
BKNG
|
+$36.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.23% |
| 2 | Industrials | 13.43% |
| 3 | Financials | 12.16% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Healthcare | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Lattice Semiconductor
LSCC
$17.6B
| $6.73M | 0.11% |
858,422
-47,177
| -5% | -$322K |
|
227
Cinemark Holdings
CNK
$3.82B
| $6.61M | 0.11% |
227,979
+169,739
| +291% | +$5.09M |
|
228
Harmonic Inc
HLIT
$1.21B
| $6.54M | 0.11% |
915,374
-11,300
| -1% | -$75.9K |
|
229
AXIS Capital
AXS
$8.59B
| $6.51M | 0.11% |
141,962
-141,300
| -50% | -$6.34M |
|
230
Wells Fargo
WFC
$261B
| $6.5M | 0.11% |
130,640
-286,270
| -69% | -$13.3M |
|
|
ELX
231
DELISTED
EMULEX CORP
ELX
| $6.42M | 0.11% |
868,494
+11,281
| +1% | +$82.9K |
|
|
CPLA
232
DELISTED
Capella Education Company
CPLA
| $6.41M | 0.11% |
101,526
-41,626
| -29% | -$2.7M |
|
|
OVTI
233
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
| $6.41M | 0.11% |
361,958
+315,408
| +678% | +$5.12M |
|
|
SDRL
234
DELISTED
Seadrill Limited Common Stock
SDRL
| $6.32M | 0.11% |
+671
| New | +$6.6M |
|
|
THS
235
DELISTED
Treehouse Foods
THS
| $5.91M | 0.1% |
82,036
-61,749
| -43% | -$4.26M |
|
|
SIMG
236
DELISTED
SILICON IMAGE INC
SIMG
| $5.9M | 0.1% |
855,602
-58,700
| -6% | -$362K |
|
237
Benchmark Electronics
BHE
$2.91B
| $5.86M | 0.1% |
258,521
-5,500
| -2% | -$128K |
|
238
Royal Caribbean
RCL
$78.7B
| $5.85M | 0.1% |
107,142
+87,742
| +452% | +$4.45M |
|
|
ZNGA
239
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $5.79M | 0.1% |
+1,345,852
| New | +$6.2M |
|
|
EGN
240
DELISTED
Energen
EGN
| $5.72M | 0.1% |
70,760
-5,010
| -7% | -$376K |
|
|
PFPT
241
DELISTED
Proofpoint, Inc.
PFPT
| $5.66M | 0.09% |
152,679
+110,356
| +261% | +$4.31M |
|
|
AXE
242
DELISTED
Anixter International Inc
AXE
| $5.66M | 0.09% |
55,758
+42,158
| +310% | +$4.12M |
|
243
Edgewell Personal Care
EPC
$1.27B
| $5.61M | 0.09% |
75,126
| – | – |
|
244
Evercore
EVR
$13.1B
| $5.54M | 0.09% |
100,350
-9,420
| -9% | -$539K |
|
|
PXD
245
DELISTED
Pioneer Natural Resource Co.
PXD
| $5.5M | 0.09% |
+29,410
| New | +$5.37M |
|
|
TIVO
246
DELISTED
TIVO INC
TIVO
| $5.43M | 0.09% |
410,215
-861,125
| -68% | -$11.1M |
|
247
Strategy Inc
MSTR
$33.5B
| $5.41M | 0.09% |
468,990
+85,640
| +22% | +$1.07M |
|
248
AbbVie
ABBV
$458B
| $5.41M | 0.09% |
105,150
+92,250
| +715% | +$4.66M |
|
|
GLF
249
DELISTED
GulfMark Offshore, Inc. Common Stock
GLF
| $5.38M | 0.09% |
119,811
-7,370
| -6% | -$327K |
|
250
Old Republic International
ORI
$10.3B
| $5.31M | 0.09% |
323,960
+12,590
| +4% | +$200K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2014 Portfolio in Review
As of Q1 2014, Jacobs Levy Equity Management held 1,150 positions worth $5.97B, down 10% from $6.66B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jacobs Levy Equity Management withdrew a net $778M in Q1 2014, closing 276 positions and reducing 398 holdings. Its most notable exit was Allergan Inc, an estimated $52.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Financials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bristol-Myers Squibb worth $35.5M.
- Jacobs Levy Equity Management's largest Q1 2014 buy was Bristol-Myers Squibb: 683,110 shares worth $35.5M.
- Jacobs Levy Equity Management added most to Amazon in Q1 2014, an estimated $51.8M increase.
- Jacobs Levy Equity Management's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $40.3M.
- Jacobs Levy Equity Management fully exited Allergan Inc in Q1 2014, selling an estimated $52.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.97B portfolio in Q1 2014.
- Jacobs Levy Equity Management opened 217 new positions and closed 276 in Q1 2014.
- Jacobs Levy Equity Management's portfolio value fell 10% quarter-over-quarter to $5.97B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2014, filed 15 May 2014.